Duraibabu Prathyusha Insider Trades

Insider Trading History

Track insider trading activity for Duraibabu Prathyusha. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Organogenesis Holdings
Organogenesis Holdings ORGO
Director
Holding Value $600k 247,047 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$187k 48,828 shares
$3.84
$2.43
Sangamo Therapeutics
Sangamo Therapeutics SGMO
PRINCIPAL FINANCIAL OFFICER
Holding Value $48.2k 660,042 shares
Last Trade
Jan 22, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.7k 36,676 shares
$0.40
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
PRINCIPAL FINANCIAL OFFICER
Holding Value $50.9k 696,718 shares
Last Trade
Nov 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.07k 2,544 shares
$0.42
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
PRINCIPAL FINANCIAL OFFICER
Holding Value $51.1k 699,262 shares
Last Trade
Oct 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.8k 45,225 shares
$0.66
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $54.4k 744,487 shares
Last Trade
Aug 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.06k 1,792 shares
$0.59
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $54.6k 746,279 shares
Last Trade
Jul 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.3k 31,866 shares
$0.48
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $56.9k 778,145 shares
Last Trade
May 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$842 1,792 shares
$0.47
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $57k 779,937 shares
Last Trade
Apr 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$24.9k 31,866 shares
$0.78
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $59.3k 811,803 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$538k 560,000 shares
$0.96
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $50.6k 691,803 shares
Last Trade
Feb 25, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.32k 1,375 shares
$0.96
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $50.7k 693,178 shares
Last Trade
Feb 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.79k 1,792 shares
$1.00
$0.07
Organogenesis Holdings
Organogenesis Holdings ORGO
Director
Holding Value $482k 198,219 shares
Last Trade
Feb 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 49,575 shares
$3.53
$2.43
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $50.8k 694,970 shares
Last Trade
Jan 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$149k 129,242 shares
$1.15
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $60.2k 824,212 shares
Last Trade
Nov 25, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.66k 1,371 shares
$1.94
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $60.4k 825,583 shares
Last Trade
Nov 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.36k 1,787 shares
$1.88
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $60.5k 827,370 shares
Last Trade
Aug 25, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.18k 1,371 shares
$0.86
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $60.6k 828,741 shares
Last Trade
Aug 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.54k 1,787 shares
$0.86
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $60.7k 830,528 shares
Last Trade
Jun 11, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$544 892 shares
$0.61
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $60.8k 831,420 shares
Last Trade
May 25, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$823 1,371 shares
$0.60
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $60.9k 832,791 shares
Last Trade
May 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.07k 1,787 shares
$0.60
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up